Synucleinopathy in amyotrophic lateral sclerosis: a potential avenue for antisense therapeutics?

B Roberts, F Theunissen, FL Mastaglia… - International Journal of …, 2022 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is the most common adult-onset motor neuron disease
classified as both a neurodegenerative and neuromuscular disorder. With a complex …

A report of resources used by clinicians in the UK to support motor neuron disease genomic testing

J Howard, HL Bekker, CJ Mcdermott… - … Lateral Sclerosis and …, 2024 - Taylor & Francis
Genetic testing is a key decision-making point for people with motor neuron disease (MND);
to establish eligibility for clinical trials, better understand the cause of their condition, and …